IP Library Granted Patent US 7,745,423
Granted Patent B2
US 7,745,423 · App. 12/130,005 · Granted Jun 29, 2010

Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin

Assignees: NormOxys, Inc; Universite de Strasbourg
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,745,423
App. No.
12/130,005
Granted
Jun 29, 2010
Kind
B2
Abstract

The present invention relates to mixed calcium/sodium salt of inositol tripyrophosphate, methods of preparing and methods of use. The mixed calcium/sodium salt may be a monocalcium tetrasodium salt of inositol tripyrophosphate. Methods of use include administering the above salts in an effective amount to treat diseases caused by hypoxia or other conditions associated with inadequate function of the lungs or circulatory system, such as various types of cancer and Alzheimer's disease.

Claims (6)

1. A method of making a monocalcium tetrasodium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate comprising;

a) passing a myo-inositol hexakisphosphate salt over an ion exchange column to obtain a free inositol tripyrophosphate acid,

b) reacting the free myo-inositol tripyrophosphate acid with triethylamine to form a hexatriethylammonium myo-inositol hexakisphosphate,

c) reacting the hexatriethylammonium myo-inositol hexakisphosphate with dicyclohexylcarbodiimide dissolved in acetonitrile to form a hexatriethylammonium myo-inositol 1,6:2,3:4,5 trispyrophosphate,

d) passing the hexatriethylammonium myo-inositol 1,6:2,3:4,5 trispyrophosphate over an ion-exchange column followed by addition of a calcium salt containing organic compound and a sodium salt containing organic compound to form the monocalcium tetrasodium salt of myo-insotiol 1,6:2,3:4,5 tripyrophosphate.

2. The method of claim 1 , wherein the calcium salt containing organic compound is calcium hydroxide and the sodium salt containing organic compound is sodium hydroxide.

Assignments (3)
MERGER Recorded Oct 22, 2009
From: UNIVERSITE LOUIS PASTEUR
To: UNIVERSITE DE STRASBOURG
Reel/Frame 023408/0916 →
CHANGE OF NAME Recorded Jun 12, 2009
From: OXYPLUS, INC.
To: NORMOXYS, INC.
Reel/Frame 022813/0892 →
NUNC PRO TUNC ASSIGNMENT Recorded Oct 14, 2008
From: NICOLAU, YVES CLAUDE; LEHN, JEAN MARIE; FYLAKTAKIDOU, KONSTANTINA C.; GREFERATH, RUTH
To: OXYPLUS, INC.; UNIVERSITE LOUIS PASTEUR DE STRASBOURG
Reel/Frame 021676/0737 →
Continuity (7)
Continuation In Part 1149756600 · Aug 1, 2006
Continuation In Part 1139633800 · Mar 31, 2006
Continuation In Part 1117597900 · Jul 6, 2005
Continuation In Part 1138401200 · Mar 17, 2006
Provisional Application 6058580400 · Jul 6, 2004
Provisional Application 6066349100 · Mar 18, 2005
Related Publication 20090029951A1 · Jan 29, 2009